Objective:
• We aimed to determine the presence of underdiagnosed BWS in early-onset "non-syndromic" obese children in our department.
Conclusions:
• Some overgrowth syndromes, particularly BWS, can present clinically as early-onset obesity, with mild or no prenatal overgrowth and no other features, leading to misdiagnosis and misclassification as "common" obesities.
• Genetic testing for BWS should be considered in early-onset obesity. MS-MLPA is an useful and efficient diagnostic tool.
Patients and methods:
• We studied 159 children (95 males/64 females) diagnosed with early-onset (< 5 years) severe (BMI-SDS >+3 SDS) obesity.
•A custom-made methylation-specific multiple-ligand-probeassay (MS-MLPA), with HhaI as a methylation-sensitive restriction enzyme, was used to analyze blood cell DNA methylation at the 11p15.5 region. The assay contains 11 probes, including one for the imprinting-center-1 (IC1) locus (H19) and one for IC2 (KCNQ1). Probes located at fully unmethylated loci were included as technical controls, as well as probes without the HhaI recognition site for methylation quantification.
• Hypomethylation at the KCNQ1 locus was identified in two of the 157 patients. The same MS-MLPA assay was useful to discard unbalanced genomic rearrangements or uniparental disomy at this 11p15.5 region, considering that the methylation level at H19 was within the reference range.
• A decrease of 60% in the methylation level at KCNQ1 locus was detected in patient 1, while in patient 2 the reduction was approximately 33% ( Figure 1B ). The different percentage of methylation reduction suggests different degrees of mosaicism for the alteration in the two samples. Both patients with 11p15.5 epimutations had been referred to our Pediatric Endocrinology clinic due to severe childhood obesity. Neither of them fulfilled the minimum criteria for clinical diagnosis of BWS (Table) . Kidney ultrasound and plasma alpha-fetoprotein levels (after diagnosis) were normal in both girls.
• Patient 1, with a higher degree of methylation impairment, presented no single criteria for diagnosis of BWS. She had suitable birth anthropometry, height and bone age according to target height and chronological age and her obesity was ameliorating as age progressed (Figure 2 ). • Patient 2, with a lesser degree of methylation impairment, had one major [pre-(birth length and weight 53 cm and 4.0 kg, respectively) and post-natal macrosomy (height +2.7 SDS)] and two minor criteria [gestational polyhydramnios and advanced bone age (+ 2 years over chronological age)]. She presented a more severe predominantly abdominal obesity (BMI > +8 SDS) while in adolescence (Figure 3 ). Hypomethylation at IC2, which is found in 50% of BWS as well as in these two patients, is shown in the scheme below. This epigenetic alteration leads to the expression of KCNQ1OT1 on the maternal allele and subsequently reduces expression of CDKN1C and KCNQ1. Figure 1B : MS-MLPA results of both patients. Probes from the 11p15.5 region are shown in grey (H19-M2 and KCNQ1-M5), among other probes used as dosage (C1 and C2) and digestion controls (D1 and D2). In each case, the peak pattern displayed above represents the non-digested products. The patterns below display the methylation status after digestion with a methylation-sensitive restriction enzyme. No methylation alteration was detected with the H19 probe. However, a reduction in the peak of the KCNQ1 probe was detected in both patients, implying a decrease of methylation status at this locus. 
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